OptiScan Biomedical scored an FDA nod for its bedside device that continuously monitors ICU patients’ glucose levels.

Episona, which launched its epigenetic test in fertility clinics last October, is now offering it online.

A full 14 years after founding CRO Clinipace, its long-standing CEO and president, Jeff Williams, is planning to step down.

The TRK TKI achieved a median duration of response of 28.6 months, suggesting its effect may last longer than that of the incumbent.

The series B round equips the Stanford University spinout to expand trials of its CD47-targeted approach to dialing up phagocytosis of cancer cells.

A back-loaded deal with CureVac moves Lilly into an emerging field that seeks to use mRNA to guide immune attacks on tumors.

Big Pharma-backed antifibrotic startup Blade has triggered the remaining tranche of last summer’s $45 million series B after placing its bets on a leading…

Startup Vir Biotechnology, guided by former Biogen CEO George Scangos, is unveiling a multifaceted pipeline of treatments for infectious diseases.

WuXi AppTec buys U.S.-based full-service CRO ResearchPoint Global, tapping the latter's clinical operations in over 60 countries.

ReWalk Robotics is gearing up for the clinical testing of its soft suit exoskeleton, which it plans to launch next year.